Ebola Monoclonal Antibody Cocktail Patent, April 2026
Summary
The EPO published patent application EP3583122A1 titled 'Monoclonal Antibodies and Cocktails for Treatment of Ebola Infections,' filed by Mapp Biopharmaceutical, Inc., Albert Einstein College of Medicine, and Adimab, LLC. Five named inventors are listed: Bornholdt, Zeitlin, Chandran, Wec, and Walker. The application covers designated states across all EU member states plus several additional European countries.
“MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS”
About this source
GovPing monitors EPO Patent Bulletin - Pharma (A61K) for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 58 changes logged to date.
What changed
The EPO Patent Bulletin published application EP3583122A1 for monoclonal antibodies and antibody cocktails intended for treating Ebola virus infections. The application names Mapp Biopharmaceutical, Inc., Albert Einstein College of Medicine, and Adimab, LLC as co-applicants, with five named inventors. The designated states include all EU member states plus Albania, Switzerland, Norway, Iceland, Liechtenstein, Monaco, North Macedonia, Serbia, San Marino, Turkey, and Vatican City.
Pharmaceutical and biotechnology companies engaged in infectious disease therapeutic development should note this filing as part of the competitive landscape for Ebola treatments. The publication provides public notice of the pending application and opens the period for third-party observations or opposition under EPO procedures.
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MONOCLONAL ANTIBODIES AND COCKTAILS FOR TREATMENT OF EBOLA INFECTIONS
Publication EP3583122A1 Kind: A1 Apr 15, 2026
Applicants
Mapp Biopharmaceutical, Inc., Albert Einstein College of Medicine, Adimab, LLC
Inventors
BORNHOLDT, Zachary, A., ZEITLIN, Larry, CHANDRAN, Kartik, WEC, Anna, WALKER, Laura
IPC Classifications
C07K 16/10 20060101AFI20201008BHEP A61P 31/14 20060101ALI20201008BHEP A61K 39/395 20060101ALI20201008BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Parties
Related changes
Get daily alerts for EPO Patent Bulletin - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.